This article was nominated for deletion on 19 November 2019. The result of the discussion was keep. |
This article must adhere to the biographies of living persons (BLP) policy, even if it is not a biography, because it contains material about living persons. Contentious material about living persons that is unsourced or poorly sourced must be removed immediately from the article and its talk page, especially if potentially libellous. If such material is repeatedly inserted, or if you have other concerns, please report the issue to this noticeboard.If you are a subject of this article, or acting on behalf of one, and you need help, please see this help page. |
This article is rated Stub-class on Wikipedia's content assessment scale. It is of interest to the following WikiProjects: | ||||||||||||||||||||||||
|
Untitled
editthis article should not be deleted, since it contains no violations of copy-right the one external link that I put is from a site that was created by myself The article contains information on current status and research activities of Theo wallimann, an expert in creatine kinase research an renown scientist working and teaching at Swiss Federal Inst of Technology Switzerland
Hi, The problems are not the links but the text about Theo Walliman. The text is an exact copy of this copyrighted webpage [[1]]. You need to rewrite the information about Dr. Walliman in your own words, not use those of ETH Zurich. I hope that clarifies things. --Slp1 (talk) 22:15, 2 March 2008 (UTC)
- I believe he is claiming ownership of that text also, although the university put its copyright on it. But the best thing to do is just to rewrite it, since the subject is clearly notable. DGG (talk)22:43, 2 March 2008 (UTC).
- I am not so sure based on the fact that he kept taking links out of the article and refers to "the ones" belonging to him. But anyway, you are right the notability thing. I guess it isn't that long! --Slp1 (talk) 22:50, 2 March 2008 (UTC)
The ETH has no objection concerning copyright of its CV of members, instead they are interested to have their faculty on Wikpedia, the text is not exactly copy pasted but has been modified please convince yourself I thus ask the operator to reload the text that has not been written by the university but by myself, as well as the text on the University page, which was also written by faculty members themselves —Preceding unsigned comment added by LarsCedric (talk • contribs) 20:04, 29 April 2008 (UTC) If you read the two sites in a comparative fashion, you realize that the wording is different and as a matter of fact a CV has certain key points and events that are fix and cannot be changed ! —Preceding unsigned comment added by LarsCedric (talk • contribs) 06:24, 30 April 2008 (UTC)
Question: would the version below be more suitable?
Theo Wallimann, PhD, Prof. was a Research Group Leader at the Institute of Cell Biology at the ETH Zurich.
Born October 13, 1946 in Alpnach, Switzerland. he completed his dissertation 1975 with distinction at the Biology Department of the ETH Zurich and was awarded the ETH price and medal.
He worked from 1975-1981 with Professor A.G. Szent-Györgyi as a Postdoctoral Research Associate at Brandeis University in Boston, Mass., U.S.A. on the subject of "myosin-linked calcium regulation of muscle contraction".
In 1981, he was appointed Senior Assistant at the Institute of Cell Biology of the ETH Zurich by Prof. H.M. Eppenberger to work in the areas of muscle biochemistry, bioenergetics and molecular physiology of creatine kinases. In 1984, he became a lecturer (with Habilitation) and in 1994, was awarded the title of Professor. He was head of the Institute of Cell Biology in the year of 1995. Theo Wallimann retired as of May 31st. 2008 and is now an emeritus.
Prof. Wallimann's main areas of research were:
The atomic structure, function, subcellular compartmentation, as well as the regulation and molecular physiology of Creatine kinase (CK) isoenzymes and the Creatine Transporter (CRT).
The mechanisms of the observed cell & neuro-protective effects of Creatine Supplementation in health and diseases.
The structure, function, regulation and molecular physiology of AMP-activated protein kinase (AMPK), a protein kinase involved in cellular energy homeostasis and nutritional signalling in diseases such as Type 2 Diabetes, obesity, metabolic syndrome and cancer.
Wallimann was the recipient of the Alfred-Vogt Price 2005.
Weblinks: Creatine Suppementation [1] http://icbxw.ethz.ch/creatine/creatine_supplementation.html Publications of the Wallimann group [2]http://www.cell.biol.ethz.ch/research/wallimann/publications